Characteristics of Cystic Fibrosis Patients with Pulmonary Exacerbation and No Detectable CF Airway Pathogens

被引：0
|
作者：
Zemanick, E. T. [1 ]
Harris, J. K. [1 ]
Wagner, B. D. [1 ]
Accurso, F. J. [1 ]
Sagel, S. D. [1 ]
机构：
[1] Univ Colorado, Denver, CO 80202 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1787
引用
收藏
页数：1
相关论文
共 50 条
  • [21] UTILIZATION OF BODE INDEX FOR PULMONARY EXACERBATION RATES IN PATIENTS WITH CYSTIC FIBROSIS
    Afshar, K.
    Fukushima, L.
    Modi, A.
    Ahoui, A.
    Rao, A. P.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 362 - 362
  • [22] Serial Impulse Oscillometry In Patients With Cystic Fibrosis Hospitalized For Pulmonary Exacerbation
    Berger, K. I.
    Fiorino, E. K.
    Goldring, R. M.
    Giusti, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [23] Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients
    Morlacchi, Letizia Corinna
    Rosti, Valentina
    Elia, Rita
    Mantero, Marco
    Dallari, Barbara
    Galbiati, Samantha
    Zanardelli, Maddalena
    D'Adda, Alice
    Blasi, Francesco
    Pizzamiglio, Giovanna
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [24] RETROSPECTIVE APPLICATION OF PULMONARY EXACERBATION SCORE IN PEDIATRIC CYSTIC FIBROSIS PATIENTS
    Lee, J. B.
    Adcock, K. G.
    Fleming, J. W.
    Josey, D.
    Thompson, S. C.
    Majure, J. M.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S345 - S346
  • [25] Pulmonary Exacerbation Score in Cystic Fibrosis Patients: Reliability and Validity Testing
    Keller, Fabienne
    Kernen, Yann
    Ranganathan, Sarath C.
    Hafen, Gaudenz M.
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2015, 28 (03) : 172 - 176
  • [26] DO INFLAMMATORY BIOMARKERS PREDICT PULMONARY EXACERBATION IN PATIENTS WITH CYSTIC FIBROSIS?
    Emiralioglu, N.
    Aydemir, O.
    Kiper, N.
    Tugcu, G.
    Yalcin, E.
    Dogru, D.
    Ozcelik, U.
    PEDIATRIC PULMONOLOGY, 2016, 51 : S57 - S58
  • [27] Characteristics associated with cystic fibrosis-related pulmonary exacerbation treatment location
    Gold, Laura S.
    Hansen, Ryan N.
    Heltshe, Sonya L.
    Flume, Patrick A.
    Goss, Christopher H.
    West, Natalie E.
    Sanders, Don B.
    Kessler, Larry
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (02) : 278 - 281
  • [28] Intravenous fosfomycin for pulmonary exacerbation of cystic fibrosis: Real life experience of a large adult CF centre
    Spoletini, G.
    Kennedy, M.
    Flint, L.
    Graham, T.
    Etherington, C.
    Shaw, N.
    Whitaker, P.
    Denton, M.
    Clifton, I.
    Peckham, D.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 50 : 82 - 87
  • [29] The use of mobile phone technology for early detection of pulmonary exacerbation of cystic fibrosis (CF): A time to be precise
    Jarad, NA
    Sarfaraz, S
    Tarassenko, L
    O'Brien, N
    Townsend, N
    THORAX, 2004, 59 (01) : 80 - 81
  • [30] Resting energy expenditure (REE) and dietary intake during a pulmonary exacerbation in children with cystic fibrosis (CF).
    Fung, EB
    Stallings, VA
    Hofley, PM
    Scanlin, TF
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 66 (01): : 5 - 5
12345